바이오인

 

 

The National Institutes of Health (NIH) has at its mission the discovery of knowledge and therapies that will lead to better health outcomes for all Americans. NIH accomplishes this goal through a robust program of intramural and extramural research, education, and training conducted or sponsored by 27 Institutes and Centers.

The 2010 Budget provides $30.8 billion in appropriations for NIH (see Table), an increase of $443 million or 1.5 percent above the 2009 enacted level. In addition, NIH received $10.4 billion in Recovery Act funding, which will be spent in 2009 and 2010. After relatively sustained funding between 2004 and 2008, the Recovery Act provides an unprecedented increase for NIH. The 2010 Budget continues to support biomedical research.

 

 

 

The 2010 Budget includes over $6 billion to support cancer research as part of the President’s sustained commitment to double NIH-wide funding for cancer research over the next 8 years, while also maintaining growth for non-cancer research. The budget for the National Cancer Institute (NCI), the NIH leader in cancer research, increases $181 million or 3.6 percent to $5.2 billion (see Table).

In 2010, the NIH Common Fund (CF) will invest $549 million, an increase of $8 million over 2009, to support cross-cutting, trans-NIH programs that require participation by at least two NIH Institutes or Centers (ICs) or that would otherwise benefit from strategic planning and coordination (see Table). The Transformative R01 program (TRO1), a high risk/high reward initiative designed as a result of strategic planning to fund ground breaking research opportunities, will be expanded in 2010 to $70 million, double the 2009 funding level.

NIH, in partnership with other agencies in the Department of Health and Human Services (HHS), will continue to build on a total of $1.1 billion in the Recovery Act for comparative effectiveness research to produce state-of-thescience information on what medical treatments work best for a given condition. NIH’s portion of the total for comparative effectiveness research is $400 million.

 

 

....(계속)